Your browser doesn't support javascript.
loading
Natural human Bet v 1-specific IgG antibodies recognize non-conformational epitopes whereas IgE reacts with conformational epitopes.
Brazhnikov, Georgii; Smolnikov, Evgenii; Litovkina, Alla; Jiang, Tianchi; Shatilov, Artem; Tulaeva, Inna; Tulaev, Mikhail; Karaulov, Alexander; Poroshina, Alina; Zhernov, Yury; Focke-Tejkl, Margarete; Weber, Milena; Akinfenwa, Oluwatoyin; Elisyutina, Olga; Andreev, Sergey; Shilovskiy, Igor; Shershakova, Nadezhda; Smirnov, Valeriy; Fedenko, Elena; Lepeshkova, Tatiana Sergeevna; Beltyukov, Evgeny Cronidovich; Naumova, Veronika Victorovna; Kundi, Michael; Khaitov, Musa; Wiedermann, Ursula; Valenta, Rudolf; Campana, Raffaela.
Afiliação
  • Brazhnikov G; Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • Smolnikov E; Institute for Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • Litovkina A; National Research Center Institute of Immunology Federal Medical-Biological Agency of Russia, Moscow, Russia.
  • Jiang T; Department of Immunology, Institute of Medicine, RUDN University, Moscow, Russia.
  • Shatilov A; National Research Center Institute of Immunology Federal Medical-Biological Agency of Russia, Moscow, Russia.
  • Tulaeva I; Department of Immunology, Institute of Medicine, RUDN University, Moscow, Russia.
  • Tulaev M; Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • Karaulov A; National Research Center Institute of Immunology Federal Medical-Biological Agency of Russia, Moscow, Russia.
  • Poroshina A; Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • Zhernov Y; Laboratory of Immunopathology, Department of Clinical Immunology and Allergology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Focke-Tejkl M; Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • Weber M; Laboratory of Immunopathology, Department of Clinical Immunology and Allergology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Akinfenwa O; National Research Center Institute of Immunology Federal Medical-Biological Agency of Russia, Moscow, Russia.
  • Elisyutina O; F. Erismann Institute of Public Health, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Andreev S; Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • Shilovskiy I; Karl Landsteiner University of Health Sciences, Krems, Austria.
  • Shershakova N; Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • Smirnov V; Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • Fedenko E; National Research Center Institute of Immunology Federal Medical-Biological Agency of Russia, Moscow, Russia.
  • Lepeshkova TS; Department of Immunology, Institute of Medicine, RUDN University, Moscow, Russia.
  • Beltyukov EC; National Research Center Institute of Immunology Federal Medical-Biological Agency of Russia, Moscow, Russia.
  • Naumova VV; National Research Center Institute of Immunology Federal Medical-Biological Agency of Russia, Moscow, Russia.
  • Kundi M; National Research Center Institute of Immunology Federal Medical-Biological Agency of Russia, Moscow, Russia.
  • Khaitov M; National Research Center Institute of Immunology Federal Medical-Biological Agency of Russia, Moscow, Russia.
  • Wiedermann U; National Research Center Institute of Immunology Federal Medical-Biological Agency of Russia, Moscow, Russia.
  • Valenta R; Department of Polyclinic Pediatrics, Ural State Medical University, Yekaterinburg, Russia.
  • Campana R; Department of Faculty Therapy, Endocrinology, Allergology and Immunology, Ural State Medical University, Yekaterinburg, Russia.
Allergy ; 78(12): 3136-3153, 2023 12.
Article em En | MEDLINE | ID: mdl-37701941
ABSTRACT

BACKGROUND:

The nature of epitopes on Bet v 1 recognized by natural IgG antibodies of birch pollen allergic patients and birch pollen-exposed but non-sensitized subjects has not been studied in detail.

OBJECTIVE:

To investigate IgE and IgG recognition of Bet v 1 and to study the effects of natural Bet v 1-specific IgG antibodies on IgE recognition of Bet v 1 and Bet v 1-induced basophil activation.

METHODS:

Sera from birch pollen allergic patients (BPA, n = 76), allergic patients without birch pollen allergy (NBPA, n = 40) and non-allergic individuals (NA, n = 48) were tested for IgE, IgG as well as IgG1 and IgG4 reactivity to folded recombinant Bet v 1, two unfolded recombinant Bet v 1 fragments comprising the N-terminal (F1) and C-terminal half of Bet v 1 (F2) and unfolded peptides spanning the corresponding sequences of Bet v 1 and the apple allergen Mal d 1 by ELISA or micro-array analysis. The ability of Bet v 1-specific serum antibodies from non-allergic subjects to inhibit allergic patients IgE or IgG binding to rBet v 1 or to unfolded Bet v 1-derivatives was assessed by competition ELISAs. Furthermore, the ability of serum antibodies from allergic and non-allergic subjects to modulate Bet v 1-induced basophil activation was investigated using rat basophilic leukaemia cells expressing the human FcεRI which had been loaded with IgE from BPA patients.

RESULTS:

IgE antibodies from BPA patients react almost exclusively with conformational epitopes whereas IgG, IgG1 and IgG4 antibodies from BPA, NBPA and NA subjects recognize mainly unfolded and sequential epitopes. IgG competition studies show that IgG specific for unfolded/sequential Bet v 1 epitopes is not inhibited by folded Bet v 1 and hence the latter seem to represent cryptic epitopes. IgG reactivity to Bet v 1 peptides did not correlate with IgG reactivity to the corresponding Mal d 1 peptides and therefore does not seem to be a result of primary sensitization to PR10 allergen-containing food. Natural Bet v 1-specific IgG antibodies inhibited IgE binding to Bet v 1 only poorly and could even enhance Bet v 1-specific basophil activation.

CONCLUSION:

IgE and IgG antibodies from BPA patients and birch pollen-exposed non-sensitized subjects recognize different epitopes. These findings explain why natural allergen-specific IgG do not protect against allergic symptoms and suggest that allergen-specific IgE and IgG have different clonal origin.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pólen / Hipersensibilidade Alimentar Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pólen / Hipersensibilidade Alimentar Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article